tldrdailynews.com logo

Mazdutide Demonstrates Efficacy in Managing Type 2 Diabetes in Chinese Patients

1 min read
Source: Nature
TL;DR

A phase 3 trial in Chinese adults with type 2 diabetes showed that mazdutide, a dual GCGR/GLP-1R agonist, significantly improved glycemic control and promoted weight loss compared to placebo, with a favorable safety profile.

Topics:businesshealth#clinical-trial#glucose-control#health#mazdutide#type-2-diabetes#weight-loss
Share this article
  1. Mazdutide versus placebo in Chinese adults with type 2 diabetes  Nature
  2. Phase 3 Trial Shows Mazdutide Improves Blood Sugar Control in Type 2 Diabetes Patients  geneonline.com
  3. 马兹杜替德对比安慰剂治疗2型糖尿病  BIOENGINEER.ORG

Want the full story? Read the original reporting

Read on Nature